Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a sponsor to co-GP on projects in high-demand areas like San Francisco and Boston.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level to share in the promote and capitalize on emerging opportunities.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator focused on build-to-suit projects, aligning interests through co-GP equity.

Co-GP / Platform:A family office could deploy into the San Diego life science market by backing a sponsor/operator at the GP level, sharing in the promote and aligning interests to navigate the current challenges.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level to capitalize on the growing demand for specialized lab space.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of projects.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, focusing on life sciences developments that are poised for growth.

Co-GP / Platform:A family office could deploy into the Boston-Cambridge life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of lab space opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from their established networks.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor/operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a specialized operator at the GP level, securing co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a sponsor/operator at the GP level to capitalize on the influx of venture capital and NIH funding.